We are live on ! Find out more
Natixis Advisors

Natixis Advisors Portfolio holdings

AUM $71.9B
1-Year Est. Return 28.03%
This Fund
S&P 500
This Quarter Est. Return
-3.85%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$23.6B
AUM Growth
+$900M
Cap. Flow
+$1.81B
Cap. Flow %
7.66%
Top 10 Hldgs %
15.31%
Holding
1,542
New
90
Increased
818
Reduced
532
Closed
102

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$31.5M
2
NTR icon
Nutrien
NTR
+$29.5M
3
T icon
AT&T
T
+$28.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$27.6M
5
SNY icon
Sanofi
SNY
+$27.1M

Sector Composition

Rank Sector Weight
1 Technology 18.61%
2 Healthcare 14.15%
3 Financials 13.71%
4 Consumer Discretionary 9.67%
5 Industrials 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNPS icon
76
Synopsys
SNPS
$74.7B
$73.2M 0.31%
239,708
+13,048
+6% +$4.42M
DEO icon
77
Diageo
DEO
$47.4B
$72.8M 0.31%
428,643
+85,705
+25% +$15.4M
EFV icon
78
iShares MSCI EAFE Value ETF
EFV
$28.2B
$72.7M 0.31%
1,885,542
-269,481
-13% -$11.5M
DE icon
79
Deere & Co
DE
$166B
$72.5M 0.31%
217,178
+21,426
+11% +$7.34M
CAT icon
80
Caterpillar
CAT
$394B
$70.9M 0.3%
432,243
-132,662
-23% -$24.2M
HON icon
81
Honeywell
HON
$77.3B
$70.7M 0.3%
449,443
+39,962
+10% +$6.96M
BMY icon
82
Bristol-Myers Squibb
BMY
$128B
$70.7M 0.3%
994,165
-94,666
-9% -$6.87M
XOM icon
83
ExxonMobil
XOM
$641B
$69.7M 0.29%
798,127
+111,068
+16% +$10.1M
ORLY icon
84
O'Reilly Automotive
ORLY
$75.4B
$68.9M 0.29%
1,469,025
+141,780
+11% +$6.61M
MRSH
85
Marsh
MRSH
$88B
$68.3M 0.29%
457,724
+66,696
+17% +$10.7M
LOW icon
86
Lowe's Companies
LOW
$119B
$68M 0.29%
362,023
+63,079
+21% +$12.3M
MCD icon
87
McDonald's
MCD
$192B
$67.5M 0.29%
292,619
+44,851
+18% +$11.5M
CB icon
88
Chubb
CB
$139B
$67.5M 0.29%
371,195
+12,264
+3% +$2.33M
HDB icon
89
HDFC Bank
HDB
$119B
$66.8M 0.28%
2,288,206
+357,776
+19% +$11M
NOC icon
90
Northrop Grumman
NOC
$78B
$66.8M 0.28%
142,008
-4,643
-3% -$2.21M
TSM icon
91
TSMC
TSM
$2.03T
$66.5M 0.28%
969,920
-254,320
-21% -$21M
CVS icon
92
CVS Health
CVS
$136B
$66.4M 0.28%
695,783
+145,422
+26% +$14.4M
AVGO icon
93
Broadcom
AVGO
$1.81T
$65.6M 0.28%
1,477,720
+186,180
+14% +$9.51M
ADBE icon
94
Adobe
ADBE
$95.9B
$65.3M 0.28%
237,327
-31,528
-12% -$11.9M
AXP icon
95
American Express
AXP
$229B
$64.7M 0.27%
479,638
+78,447
+20% +$11.9M
PM icon
96
Philip Morris
PM
$305B
$64.1M 0.27%
771,839
-21,903
-3% -$2.09M
ZTS icon
97
Zoetis
ZTS
$32.3B
$62.9M 0.27%
424,317
-5,726
-1% -$957K
JKHY icon
98
Jack Henry & Associates
JKHY
$11B
$62.9M 0.27%
344,833
-1,611
-0.5% -$316K
LULU icon
99
lululemon athletica
LULU
$13.4B
$61.5M 0.26%
219,861
+42,550
+24% +$13.2M
VB icon
100
Vanguard Small-Cap ETF
VB
$79.7B
$61.2M 0.26%
358,278
+15,160
+4% +$2.86M

Similar funds

Natixis Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Natixis Advisors held 1,542 positions worth $23.6B, up 4% from $22.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Natixis Advisors deployed $1.81B of net new capital in Q3 2022, opening 90 new positions and adding to 818 existing holdings. Its largest new stake was Chemed: 52,930 shares worth $23.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $31.5M trimmed.

  • Natixis Advisors's largest Q3 2022 buy was Chemed: 52,930 shares worth $23.1M.
  • Natixis Advisors added most to Vanguard FTSE Developed Markets ETF in Q3 2022, an estimated $149M increase.
  • Natixis Advisors's biggest Q3 2022 reduction was Vanguard Total Stock Market ETF, cutting an estimated $31.5M.
  • Natixis Advisors fully exited Domino's in Q3 2022, selling an estimated $4.15M.
  • Natixis Advisors's ten largest holdings make up 15% of its $23.6B portfolio in Q3 2022.
  • Natixis Advisors opened 90 new positions and closed 102 in Q3 2022.
  • Natixis Advisors's portfolio value rose 4% quarter-over-quarter to $23.6B.

Based on Natixis Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.